Jim Simons Capricor Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 137,500 shares of CAPR stock, worth $3.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
137,500
Previous 53,150
158.7%
Holding current value
$3.02 Million
Previous $361,000
81.44%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CAPR
# of Institutions
70Shares Held
6.32MCall Options Held
210KPut Options Held
374K-
Black Rock Inc. New York, NY1.63MShares$35.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$34.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA642KShares$14.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny480KShares$10.5 Million0.0% of portfolio
-
State Street Corp Boston, MA401KShares$8.82 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $535M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...